MohamedBidairMD

Urology • La Mesa, CA

Physician

Join to view full profile

Dr. Bidair is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bidair's full profile

Already have an account?

Office
8881 Fletcher Pkwy
Ste 250A
La Mesa, CA 91942
Phone+1 619-229-2626

Fax+1 619-286-5412

Education & Training

University of California (San Diego) Medical CenterResidency, Urology, 1990 - 1994
University of California (San Diego) Medical CenterResidency, Surgery, 1988 - 1990
McGill University Faculty of MedicineClass of 1988

Certifications & Licensure

CA State Medical License 1989 - 2025
TX State Medical License 2023 - 2023
American Board of Urology Urology

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011

Publications & Presentations

PubMed

16 citations
Aquablation therapy in large prostates (80-150 cc) for lower urinary tract symptoms due to benign prostatic hyperplasia: WATER II 3-year trial results.
Kevin C Zorn, Mohamed Bidair, Andrew Trainer, Andrew Arther, Eugene Kramolowsky
BJUI Compass. 2022-03-01
19 citations
Five-year outcomes for Aquablation therapy compared to TURP: results from a double-blind, randomized trial in men with LUTS due to BPH.
Peter J Gilling, Neil Barber, Mohamed Bidair, Paul Anderson, Mark Sutton
The Canadian Journal of Urology. 2022-02-01
38 citations
Aquablation for Benign Prostatic Hyperplasia in Large Prostates (80-150 cc): 1-Year Results
Naeem Bhojani, Mohamed Bidair, Kevin C. Zorn, Andrew Trainer, Andrew Arther
Urology. 2021-06-01

Journal Articles

Symptom Relief and Anejaculation After Aquablation or TURP: Subgroup Analysis from a Blinded Randomized Trial
Alexis E Te, Mark Plante, Barrett Cowan, Claus Roehrborn, Mohamed Bidair, Leo Doumanian, Andrew Arther, Gopal Badlani, Mark DeGuenther, Mark Sutton, BJU International

Press Mentions

Nymox Announces Fexapotide Drug Symposium at AUA Annual Meeting San Francisco May 20May 2nd, 2018
Nymox Fexapotide Symposium and Panel Discussion at American Urological Association North Central Sectional Annual Meeting in ScottsdaleNovember 27th, 2017
Water Ablation for BPH Lessens Risk of Ejaculatory DysfunctionNovember 13th, 2017
Join now to see all